SCHEINBERG DAVID A 4
4 · SELLAS Life Sciences Group, Inc. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
SCHEINBERG DAVID A
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-03-04+7,500→ 7,500 totalExercise: $8.00Exp: 2031-03-04→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option will fully vest on the earlier of (x) March 4, 2022 (the first anniversary of the date of grant) or (y) the business day prior to the 2022 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.